Articles

The royal family’s $18 billion portfolio of assets generate bumper returns from a surge in one-off fees from wind farm developers

When investors are told that “ESG” is part of a fund manager’s strategy, they might expect to give up some potential gains while focusing on companies making efforts to comply with a set of standards for environmental, social or corporate governance factors.

Oil futures climbed Wednesday, with U.S. benchmark prices looking to score their first gain in five sessions, after official U.S. data revealed a drop in U.S. crude inventories for a fourth week in a row.

German government bond yields fell sharply on Wednesday, after surveys showed activity in the eurozone all but stalled this month as the bloc’s biggest economy contracted.

The Great Rotation has turned the market on its head. But does the trend have legs? Or is it only a matter of time before Big Tech reasserts its dominance?

New home sales dipped in June, falling to the lowest level since November 2023.

Shares of Lamb Weston Holdings Inc. plunged toward a record selloff Wednesday, after the frozen potato seller missed fiscal fourth-quarter profit expectations by a wide margin, citing a global slowdown in restaurant traffic.

The U.S. grew faster in July, a pair of S&P surveys found, in a sign the economy is still holding up well despite high interest rates and lingering inflation.

Once the Federal Reserve begins cutting interest rates, the U.S. dollar will surely fall and begin a downtrend, right? Alas, it’s never so simple.

The IT outage caused by a CrowdStrike patch that led Delta Air Lines Inc. to cancel some 6,700 flights since Friday will cost the airline $350 million and shave 200 basis points off operating margins.

AMC Entertainment Holdings Inc.’s debt restructuring this week puts the movie-theater chain and original meme stock in a good position for an expected box-office rebound, according to Benchmark.

Shares of Sage Therapeutics Inc. fell more than 18% premarket on Wednesday after a failed trial dealt a blow to the company’s collaboration with Biogen Inc.